The peroxisome proliferator-activated receptor-gamma agonist rosiglitazone increases bone resorption in women with type 2 diabetes: a randomized, controlled trial (Q43114233)
Jump to navigation
Jump to search
scientific article published on 31 March 2010
Language | Label | Description | Also known as |
---|---|---|---|
English | The peroxisome proliferator-activated receptor-gamma agonist rosiglitazone increases bone resorption in women with type 2 diabetes: a randomized, controlled trial |
scientific article published on 31 March 2010 |
Statements
1 reference
The peroxisome proliferator-activated receptor-gamma agonist rosiglitazone increases bone resorption in women with type 2 diabetes: a randomized, controlled trial (English)
1 reference
Darren K McGuire
1 reference
Colby R Ayers
1 reference
Ugis Gruntmanis
1 reference
Steve Fordan
1 reference
Hans K Ghayee
1 reference
Shuaib M Abdullah
1 reference
Raphael See
1 reference
31 March 2010
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference